BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chang L, Yang HW, Lin TY, Yang KD. Perspective of Immunopathogenesis and Immunotherapies for Kawasaki Disease. Front Pediatr 2021;9:697632. [PMID: 34350146 DOI: 10.3389/fped.2021.697632] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Roe K. Explanations for 10 of the most puzzling aspects of multisystem inflammatory syndrome and other Kawasaki-like diseases. J Clin Pharm Ther 2021. [PMID: 34729795 DOI: 10.1111/jcpt.13560] [Reference Citation Analysis]
2 Yang F, Ao X, Ding L, Ye L, Zhang X, Yang L, Zhao Z, Wang J. Non-coding RNAs in Kawasaki disease: Molecular mechanisms and clinical implications. Bioessays 2022;:e2100256. [PMID: 35355301 DOI: 10.1002/bies.202100256] [Reference Citation Analysis]
3 Mahsa Mahmoudinezhad Dezfouli S, Salehi S, Khosravi S. Pathogenic and therapeutic roles of cytokines in Kawasaki diseases. Clinica Chimica Acta 2022. [DOI: 10.1016/j.cca.2022.05.015] [Reference Citation Analysis]
4 Sharma C, Ganigara M, Galeotti C, Burns J, Berganza FM, Hayes DA, Singh-Grewal D, Bharath S, Sajjan S, Bayry J. Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison. Nat Rev Rheumatol 2021;17:731-48. [PMID: 34716418 DOI: 10.1038/s41584-021-00709-9] [Reference Citation Analysis]